Initial Evaluation of Fenofibrate for Efficacy in Aiding Smoking Abstinence

INTRODUCTION: Primate and rodent models show that peroxisome proliferator-activated receptor-alpha (PPAR-α) ligands, including fibrate medications, reduce nicotine reinforcement, reward, and related effects. We tested fenofibrate, the most common US Food and Drug Administration-approved fibrate for...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Nicotine Tob Res
Main Authors: Perkins, Kenneth A., Karelitz, Joshua L., Michael, Valerie C., Fromuth, Margaret, Conklin, Cynthia A., Chengappa, K. N. Roy, Hope, Chris, Lerman, Caryn
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2016
Assuntos:
Original Investigation
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4881827/
https://ncbi.nlm.nih.gov/pubmed/25895948
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ntr/ntv085
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares